MedX Health Corp (MDXHF)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 7.83 Million CAD | 0.89% |
| 2022 | 7.76 Million CAD | 77.97% |
| 2021 | 4.36 Million CAD | 55.52% |
| 2020 | 2.8 Million CAD | -15.09% |
| 2019 | 3.3 Million CAD | 50.37% |
| 2018 | 2.19 Million CAD | 1.07% |
| 2017 | 2.17 Million CAD | -17.16% |
| 2016 | 2.62 Million CAD | -13.86% |
| 2015 | 3.04 Million CAD | 11.29% |
| 2014 | 2.73 Million CAD | -31.53% |
| 2013 | 3.99 Million CAD | -19.03% |
| 2012 | 4.93 Million CAD | -6.16% |
| 2011 | 5.25 Million CAD | 26.4% |
| 2010 | 4.16 Million CAD | 10.46% |
| 2009 | 3.76 Million CAD | 59.54% |
| 2008 | 2.36 Million CAD | -57.26% |
| 2007 | 5.52 Million CAD | 41.2% |
| 2006 | 3.91 Million CAD | 11.28% |
| 2005 | 3.51 Million CAD | 24.95% |
| 2004 | 2.81 Million CAD | 15.11% |
| 2003 | 2.44 Million CAD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 8.7 Million CAD | 11.18% |
| 2024 Q2 | 9.22 Million CAD | 5.9% |
| 2023 Q3 | 8.44 Million CAD | 3.93% |
| 2023 Q4 | 7.83 Million CAD | -7.28% |
| 2023 Q2 | 8.12 Million CAD | 7.19% |
| 2023 Q1 | 7.58 Million CAD | -2.33% |
| 2023 FY | 7.83 Million CAD | 0.89% |
| 2022 Q4 | 7.76 Million CAD | 13.41% |
| 2022 Q1 | 4.86 Million CAD | 11.64% |
| 2022 Q2 | 6.08 Million CAD | 24.89% |
| 2022 FY | 7.76 Million CAD | 77.97% |
| 2022 Q3 | 6.84 Million CAD | 12.55% |
| 2021 Q2 | 4.93 Million CAD | -5.1% |
| 2021 Q4 | 4.36 Million CAD | -14.98% |
| 2021 FY | 4.36 Million CAD | 55.52% |
| 2021 Q1 | 5.2 Million CAD | 85.43% |
| 2021 Q3 | 5.12 Million CAD | 3.94% |
| 2020 Q1 | 2.42 Million CAD | -26.69% |
| 2020 Q4 | 2.8 Million CAD | 33.55% |
| 2020 FY | 2.8 Million CAD | -15.09% |
| 2020 Q2 | 1.9 Million CAD | -21.12% |
| 2020 Q3 | 2.09 Million CAD | 9.95% |
| 2019 Q4 | 3.3 Million CAD | 11.21% |
| 2019 FY | 3.3 Million CAD | 50.37% |
| 2019 Q3 | 2.96 Million CAD | 8.52% |
| 2019 Q2 | 2.73 Million CAD | 15.54% |
| 2019 Q1 | 2.36 Million CAD | 7.84% |
| 2018 FY | 2.19 Million CAD | 1.07% |
| 2018 Q2 | 1.64 Million CAD | -1.87% |
| 2018 Q1 | 1.67 Million CAD | -22.81% |
| 2018 Q3 | 1.81 Million CAD | 10.2% |
| 2018 Q4 | 2.19 Million CAD | 21.08% |
| 2017 FY | 2.17 Million CAD | -17.16% |
| 2017 Q1 | 2.7 Million CAD | 3.14% |
| 2017 Q2 | 2.49 Million CAD | -7.79% |
| 2017 Q4 | 2.17 Million CAD | -16.8% |
| 2017 Q3 | 2.61 Million CAD | 4.69% |
| 2016 FY | 2.62 Million CAD | -13.86% |
| 2016 Q4 | 2.62 Million CAD | -11.02% |
| 2016 Q3 | 2.94 Million CAD | -2.52% |
| 2016 Q1 | 3.19 Million CAD | 4.99% |
| 2016 Q2 | 3.02 Million CAD | -5.41% |
| 2015 Q4 | 3.04 Million CAD | 3.87% |
| 2015 Q3 | 2.93 Million CAD | -10.3% |
| 2015 Q2 | 3.26 Million CAD | 22.55% |
| 2015 Q1 | 2.66 Million CAD | -2.53% |
| 2015 FY | 3.04 Million CAD | 11.29% |
| 2014 FY | 2.73 Million CAD | -31.53% |
| 2014 Q3 | 2.87 Million CAD | -10.01% |
| 2014 Q4 | 2.73 Million CAD | -4.7% |
| 2014 Q2 | 3.19 Million CAD | -16.31% |
| 2014 Q1 | 3.81 Million CAD | -4.6% |
| 2013 Q3 | 5.33 Million CAD | 0.07% |
| 2013 Q2 | 5.33 Million CAD | 4.48% |
| 2013 Q1 | 5.1 Million CAD | 3.47% |
| 2013 Q4 | 3.99 Million CAD | -25.15% |
| 2013 FY | 3.99 Million CAD | -19.03% |
| 2012 Q2 | 5.76 Million CAD | 6.56% |
| 2012 Q3 | 6.08 Million CAD | 5.6% |
| 2012 Q4 | 4.93 Million CAD | -18.91% |
| 2012 FY | 4.93 Million CAD | -6.16% |
| 2012 Q1 | 5.4 Million CAD | 2.85% |
| 2011 Q3 | 5.01 Million CAD | 6.68% |
| 2011 FY | 5.25 Million CAD | 26.4% |
| 2011 Q4 | 5.25 Million CAD | 4.85% |
| 2011 Q2 | 4.7 Million CAD | 10.0% |
| 2011 Q1 | 4.27 Million CAD | 2.73% |
| 2010 Q2 | 4.13 Million CAD | 6.66% |
| 2010 Q4 | 4.16 Million CAD | 4.03% |
| 2010 FY | 4.16 Million CAD | 10.46% |
| 2010 Q3 | 4 Million CAD | -3.32% |
| 2010 Q1 | 3.87 Million CAD | 2.97% |
| 2009 Q3 | 3.54 Million CAD | 10.0% |
| 2009 Q4 | 3.76 Million CAD | 6.17% |
| 2009 Q1 | 2.81 Million CAD | 19.33% |
| 2009 FY | 3.76 Million CAD | 59.54% |
| 2009 Q2 | 3.22 Million CAD | 14.48% |
| 2008 Q1 | 2.55 Million CAD | -53.83% |
| 2008 Q2 | 2.31 Million CAD | -9.18% |
| 2008 FY | 2.36 Million CAD | -57.26% |
| 2008 Q3 | 1.73 Million CAD | -24.99% |
| 2008 Q4 | 2.36 Million CAD | 35.88% |
| 2007 Q1 | 4.39 Million CAD | 12.45% |
| 2007 Q2 | 4.6 Million CAD | 4.63% |
| 2007 Q3 | 4.85 Million CAD | 5.56% |
| 2007 Q4 | 5.52 Million CAD | 13.69% |
| 2007 FY | 5.52 Million CAD | 41.2% |
| 2006 Q3 | 3.68 Million CAD | 14.29% |
| 2006 Q4 | 3.91 Million CAD | 6.2% |
| 2006 Q2 | 3.22 Million CAD | -5.09% |
| 2006 Q1 | 3.39 Million CAD | -3.39% |
| 2006 FY | 3.91 Million CAD | 11.28% |
| 2005 Q2 | 2.31 Million CAD | 31.79% |
| 2005 Q4 | 3.51 Million CAD | 30.28% |
| 2005 Q3 | 2.69 Million CAD | 16.66% |
| 2005 Q1 | 1.75 Million CAD | -37.62% |
| 2005 FY | 3.51 Million CAD | 24.95% |
| 2004 Q4 | 2.81 Million CAD | 0.0% |
| 2004 FY | 2.81 Million CAD | 15.11% |
| 2003 FY | 2.44 Million CAD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| AVITA Medical, Inc. | 19.86 Million USD | 60.577% |
| Manhattan Scientifics, Inc. | 2.11 Million USD | -269.757% |
| Össur hf. | 688.8 Million USD | 98.863% |
| QHSLab, Inc. | 2.05 Million USD | -280.713% |
| Wellstar International, Inc. | 55.99 Million USD | 86.013% |
| Össur hf. | 688.8 Million USD | 98.863% |
| CVR Medical Corp. | - USD | -Infinity% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| Escalon Medical Corp. | 2.94 Million USD | -165.623% |
| Aurora Spine Corporation | 6.65 Million USD | -17.704% |
| BrainsWay Ltd. | 15.31 Million USD | 48.861% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| BioElectronics Corporation | 16.62 Million USD | 52.887% |
| Hamilton Thorne Ltd. | 45.84 Million USD | 82.917% |
| Vivos Inc. | 245 Thousand USD | -3096.463% |
| Kelyniam Global, Inc. | 1.01 Million USD | -673.146% |
| REMSleep Holdings, Inc. | 275.61 Thousand USD | -2741.461% |
| Zecotek Photonics Inc. | 5.86 Million USD | -33.447% |
| Avitar, Inc. | 11.59 Million USD | 32.45% |
| Nanomix Corporation | 14.81 Million USD | 47.137% |
| EKF Diagnostics Holdings plc | 16.08 Million USD | 51.298% |
| Theraclion SA | 13.01 Million EUR | 39.835% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Positron Corporation | 2.02 Million USD | -286.548% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 3.62 Million USD | -116.269% |
| Lombard Medical, Inc. | 53.79 Million USD | 85.442% |
| ALR Technologies Inc. | 24.5 Million USD | 68.042% |
| Stratec SE | 271.97 Million USD | 97.12% |
| Vycor Medical, Inc. | 4.31 Million USD | -81.377% |
| Heart Tronics, Inc. | 1.09 Million USD | -615.34% |
| MicroPort Scientific Corporation | 2.48 Billion USD | 99.685% |
| VMS Rehab Systems, Inc. | 201.36 USD | -3889184.366% |
| NewCardio, Inc. | 6.01 Million USD | -30.25% |
| Guided Therapeutics, Inc. | 5.47 Million USD | -43.04% |
| Ingen Technologies, Inc. | 5.7 Million USD | -37.164% |
| Odyssey Group International, Inc. | 6.61 Million USD | -18.448% |
| CYduct Diagnostics, Inc. | 2.44 Million USD | -219.677% |
| Wellness Center USA, Inc. | 5.12 Million USD | -52.833% |
| SANUWAVE Health, Inc. | 65.59 Million USD | 88.061% |
| IR-Med Inc. | 634 Thousand USD | -1135.247% |
| Perimeter Medical Imaging AI, Inc. | 5.47 Million USD | -43.0% |
| Polarean Imaging plc | 2.58 Million USD | -203.482% |
| United American Healthcare Corporation | 119 Thousand USD | -6481.061% |
| ECGI Holdings, Inc. | 11.94 Million USD | 34.412% |
| Nu-Med Plus, Inc. | 2.35 Million USD | -232.012% |
| Capital Group Holdings, Inc. | 1.32 Million USD | -491.507% |
| ADM Tronics Unlimited, Inc. | 1.44 Million USD | -441.469% |
| Medical Supply International USA, Inc. | 677.61 Thousand USD | -1055.738% |
| Urologix, Inc. | 12.64 Million USD | 38.062% |
| Rapid Therapeutic Science Laboratories, Inc. | 5.39 Million USD | -45.133% |
| Nexeon MedSystems Inc. | 8.48 Million USD | 7.675% |
| SS Innovations International, Inc. | 11.18 Million USD | 29.958% |
| Qualis Innovations, Inc. | 525.38 Thousand USD | -1390.608% |
| Smith & Nephew plc | 4.76 Billion USD | 99.836% |
| NIOX Group Plc | 9.8 Million USD | 20.104% |
| Fuse Medical, Inc. | 15.11 Million USD | 48.171% |
| Broncus Holding Corporation | 10.43 Million USD | 24.93% |
| Brain Scientific Inc. | 7.42 Million USD | -5.454% |
| Pressure BioSciences, Inc. | 33.8 Million USD | 76.832% |
| Health Logic Interactive Inc. | 794.08 Thousand USD | -886.23% |